The giant E3 ligase HUWE1 is linked to tumorigenesis, spermatogenesis, intellectual disability, and inflammatory diseases.

Front Cell Infect Microbiol

Key Laboratory for Experimental Teratology of the Ministry of Education, Department of Clinical Laboratory/Qilu Hospital, Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, China.

Published: August 2022

E3 ubiquitin ligases determine the substrate specificity and catalyze the ubiquitination of lysine residues. HUWE1 is a catalytic HECT domain-containing giant E3 ligase that contains a substrate-binding ring structure, and mediates the ubiquitination of more than 40 diverse substrates. HUWE1 serves as a central node in cellular stress responses, cell growth and death, signal transduction, etc. The expanding atlas of HUWE1 substrates presents a major challenge for the potential therapeutic application of HUWE1 in a particular disease. In addition, HUWE1 has been demonstrated to play contradictory roles in certain aspects of tumor progression in either an oncogenic or a tumor-suppressive manner. We recently defined novel roles of HUWE1 in promoting the activation of multiple inflammasomes. Inflammasome activation-mediated immune responses might lead to multifunctional effects on tumor therapy, inflammation, and autoimmune diseases. In this review, we summarize the known substrates and pleiotropic functions of HUWE1 in different types of cells and models, including its involvement in development, cancer, neuronal disorder and infectious disease. We also discuss the advances in cryo-EM-structural analysis for a functional-mechanistic understanding of HUWE1 in modulating the multitudinous diverse substrates, and introduce the possibility of revisiting the comprehensive roles of HUWE1 in multiple aspects within one microenvironment, which will shed light on the potential therapeutic application of targeting giant E3 ligases like HUWE1.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355080PMC
http://dx.doi.org/10.3389/fcimb.2022.905906DOI Listing

Publication Analysis

Top Keywords

huwe1
11
giant ligase
8
diverse substrates
8
potential therapeutic
8
therapeutic application
8
roles huwe1
8
ligase huwe1
4
huwe1 linked
4
linked tumorigenesis
4
tumorigenesis spermatogenesis
4

Similar Publications

The identification of pathways that control elimination of protein inclusions is essential to understand the cellular response to proteotoxicity, particularly in the nuclear compartment, for which our knowledge is limited. We report that stress-induced nuclear inclusions related to the nucleolus are eliminated upon stress alleviation during the recovery period. This process is independent of autophagy/lysosome and CRM1-mediated nuclear export pathways, but strictly depends on the ubiquitin-activating E1 enzyme, UBA1, and on nuclear proteasomes that are recruited into the formed inclusions.

View Article and Find Full Text PDF
Article Synopsis
  • Cutaneous T-cell lymphoma (CTCL) is a type of skin cancer that affects T cells and can spread throughout the body, making current treatments like chemotherapy less effective and often accompanied by severe side effects.
  • Research has identified cyclin dependent kinase 9 (CDK9) as a key factor in CTCL growth, with specific malignant T-cell characteristics revealed through single-cell RNA sequencing.
  • Targeting CDK9 with specialized treatments like PROTACs not only significantly reduces CTCL cell growth but also, when combined with all-trans retinoic acid (ATRA), shows promise for more effective and complete treatment options.
View Article and Find Full Text PDF
Article Synopsis
  • Turner-type X-linked syndromic intellectual developmental disorder (MRXST) is linked to variants in the HUWE1 gene and manifests through global developmental delays, intellectual disabilities, and unique facial features.
  • This study examined two families with MRXST, identifying genetic variations in HUWE1 through whole-exome sequencing and noting different inheritance patterns.
  • The research highlights consistent clinical features across cases, emphasizing the role of the HUWE1 gene in development, and proposes a monitoring protocol to improve diagnosis and management for affected individuals.
View Article and Find Full Text PDF

The E3 ligase HUWE1 interacts with ubiquitin non-covalently via key residues in the HECT domain.

FEBS Lett

November 2024

Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, China.

HUWE1, a HECT E3 ligase, is critical for processes like protein degradation and tumor development. Contrary to previous findings which suggested minimal non-covalent interactions between the HUWE1 HECT domain and ubiquitin, we identified a non-covalent interaction between the HUWE1 HECT N-lobe and ubiquitin using NMR spectroscopy, revealing a conserved ubiquitin-binding mode shared across HECT E3 ligases. Molecular dynamics simulations not only confirmed the stability of this interaction but also uncovered conformational changes in key residues, which likely influence binding affinity.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to find predictors for how well rheumatoid arthritis patients respond to the drug tofacitinib, using a method called phage immunoprecipitation sequencing (PhIP-Seq) to identify relevant biomarkers.
  • A total of 106 patients were involved, with testing to determine therapeutic response and antibody levels for validation, leading to the identification of anti-SNRK and anti-HUWE1 antibodies as potential predictors of positive treatment outcomes.
  • Results showed that anti-SNRK antibody levels were especially significant in predicting good responses and decreased in patients who responded well to treatment, marking them as key biomarkers for future therapeutic strategies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!